0001564590-14-003828.txt : 20140815 0001564590-14-003828.hdr.sgml : 20140815 20140815140222 ACCESSION NUMBER: 0001564590-14-003828 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140811 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20140815 DATE AS OF CHANGE: 20140815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ZYNEX INC CENTRAL INDEX KEY: 0000846475 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 870403828 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 033-26787-D FILM NUMBER: 141046079 BUSINESS ADDRESS: STREET 1: 9990 PARK MEADOWS DRIVE CITY: LONE TREE STATE: CO ZIP: 80124 BUSINESS PHONE: (303) 703-4906 MAIL ADDRESS: STREET 1: 9990 PARK MEADOWS DRIVE CITY: LONE TREE STATE: CO ZIP: 80124 FORMER COMPANY: FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20050812 FORMER COMPANY: FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC DATE OF NAME CHANGE: 20040120 FORMER COMPANY: FORMER CONFORMED NAME: FOX RIVER HOLDINGS INC DATE OF NAME CHANGE: 20031126 8-K 1 zyxi-8k_20140811.htm 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8‑K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): August 11, 2014

Zynex, Inc.

(Exact name of Registrant as specified in its charter)

Nevada

33-26787-D

90-0275169

(State or other jurisdiction

of incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

9990 Park Meadows Drive

Lone Tree, Colorado              

 

 

 

80124

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (303) 703-4906

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On August 11, 2014, Zynex, Inc. (the “Company”) entered into an employment agreement (the “Employment Agreement”) with Brian Alleman, the Company’s Chief Financial Officer.  Pursuant to the terms of the Employment Agreement, Mr. Alleman will receive $15,000 for the initial 30 days of his employment, and after the initial 30 day period, Mr. Alleman’s annual base salary will be $208,000.  In connection with his employment, the Company granted Mr. Alleman a stock option to purchase 350,000 shares of the Company’s common stock, at an exercise price of $0.24 per share, subject to the terms of the Company’s 2005 Stock Option Plan.  The Employment Agreement also provides that Mr. Alleman is entitled to receive certain cash incentives and additional equity awards based on the achievement of certain performance objectives.

 

The foregoing description of the Employment Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Employment Agreement, which is attached hereto as Exhibit 10.1, and is incorporated herein by reference.  

 

Item 9.01.Financial Statements and Exhibits.

 

(d)  Exhibits.

 

Exhibit
No.

 

Description

 

 

 

10.1

 

Employment Agreement, dated August 11, 2014, between Zynex, Inc. and Brian Alleman.

 

 

 

 

 



SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Zynex, Inc.

Date:

August 15, 2014

By:

/s/ Thomas Sandgaard

 

 

 

Thomas Sandgaard

 

 

 

Chief Executive Officer

 

 

 


EXHIBIT INDEX

 

Exhibit
No.

 

Description

 

 

 

10.1

 

Employment Agreement, dated August 11, 2014, between Zynex, Inc. and Brian Alleman.

 

EX-10.1 2 zyxi-ex101_2014081118.htm EX-10.1

Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

This Employment Agreement (this “Agreement”) is between ZYNEX, Inc., a Nevada corporation (the “Company”), and the undersigned (“you”) and is effective as of the “Effective Date” set forth below.

 

1.

Title and Salary.  You will be employed full-time as the Chief Financial Officer of the Company commencing on July 15, 2014 (the “Effective Date”).  For the first 30 days you will be paid a flat rate of $15,000. After the initial 30 days, your compensation will consist of an annual base salary of $208,000. In addition you will be granted options to purchase 350,000 shares of the Company’s common stock at the closing price on August 8, 2014, subject to the terms of the Company’s 2005 Stock Option Plan.

2.

Incentive Compensation.  You you will be eligible to earn incentive compensation as follows:

 

2014 Incentives:

 

Incentive

Q3 10-Q’s filed timely (No NT and not late)

10,000 stock options

Replacement of Triumph LOC

50,000 stock options

Q4 EBIDTA profitable by >$500k

50,000 stock options

Zynex Stock Price above $1.00/share

50,000 stock options

Zynex Stock Volume above 100,000 shares/day (13 week average)

100,000 stock options (50,000 options if above 50,000 shares/day

 

2015 Incentives:

 

 

Incentive

Net Revenue > $6M per quarter

Quarterly

10,000 stock options per quarter

EBITDA > $500k per quarter

Quarterly

20,000 stock options per quarter

Free Cash Flow > $500k per quarter

Quarterly

25,000 stock options per quarter

EBITDA above $1,8M y/e 12/31/2015

EBITDA above $2.25M y/e 12/31/2015

Y/E 12/31/2015

75,000 stock options + $50,000

125,000 stock options + $75,000

Zynex Stock Price above $2.00/share

Half if $1/s

50,000 stock options +$25,000

Zynex Stock Volume above 150,000 shares/day (13 week average)

Half if above 100,000

100,000 stock options + $25,000

 

3.   Benefits.  You will be entitled to four (4) weeks of paid personal time off (“PTO”) per year, which shall cover all vacation, personal, or sick days.  PTO will accrue ratably on a monthly basis.  You may carry over up to one (1) week of unused PTO to the following year.  Any additional personal time off used or received, for whatever reason, shall be unpaid.  The Company recognizes all federal holidays and other holidays as determined by the Company from time to time in its sole discretion.  You acknowledge and agree that you have existing health insurance coverage and hereby decline coverage under the Company’s health insurance plans. The Company may adopt, cancel or modify benefit programs from time to time in its sole discretion.

4.    Employment “At-Will”.  Employment with the Company is at will and may be terminated by you or the Company at any time, with or without cause.  No representative of the Company has the authority to offer employment other than at-will employment except in a written employment contract signed by the president of the Company.

5.    Acceptance.  To signify your acceptance of this Agreement, please sign and return this Agreement to the undersigned representative of the Company.

 

Employee

 

/s/ Brian P. Alleman_________________________

Brian P. Alleman

 

8/11/2014_________________________________

(Date)

 

Company:  ZYNEX, Inc.

 

/s/ Thomas Sandgaard_______________________

Thomas Sandgaard, Chief Executive Officer

 

8/11/2014_________________________________

(Date)